Compare Eaton Corporation plc (ETN) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Medpace Holdings Inc — how do they compare? Eaton Corporation plc trades at $429.65 (market cap $164.88B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Eaton Corporation plc is far larger — about 9.8× Medpace Holdings Inc's market cap, and Eaton Corporation plc pays a 1.04% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Medpace Holdings Inc for 14 Days on average.
| ETN | MEDP | |
|---|---|---|
Market Cap | $164.88B | $16.82B |
Volume | 2,535,086 | 223,093 |
Sector | Industrials | Health |
52-Week High | $459.96 | $630.19 |
52-Week Low | $315.82 | $393.42 |
Typical Hold Time | 31 Days | 14 Days |
Enterprise Value | $185.51B | $16.44B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $424.51, down 1.58% over the past day, amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability metrics include a 12.75% net income margin and 19.71% ROE. Recent news highlights strategic acquisitions in data center and utility markets, positioning the company for durable growth from AI and grid modernization trends.
Outlook remains positive with a consensus price target of $502.38, implying significant upside. Risks include execution of acquisitions and potential margin pressure from increased investing outlays. Analyst sentiment is strongly bullish with 70% buy ratings, though technical indicators suggest near-term caution.
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
